These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26600308)

  • 21. Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial.
    Ravnborg M; Sørensen PS; Andersson M; Celius EG; Jongen PJ; Elovaara I; Bartholomé E; Constantinescu CS; Beer K; Garde E; Sperling B
    Lancet Neurol; 2010 Jul; 9(7):672-80. PubMed ID: 20542736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.
    Sorensen PS; Mellgren SI; Svenningsson A; Elovaara I; Frederiksen JL; Beiske AG; Myhr KM; Søgaard LV; Olsen IC; Sandberg-Wollheim M
    Lancet Neurol; 2009 Jun; 8(6):519-29. PubMed ID: 19409854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum BAFF levels and skin mRNA expression in patients with Behçet's disease.
    Hamzaoui K; Houman H; Ben Dhifallah I; Kamoun M; Hamzaoui A
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S64-71. PubMed ID: 19026118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral blood cell immunomarkers in the course of methylprednisolone treatment of multiple sclerosis relapses.
    Michałowska-Wender G; Wender M
    Folia Neuropathol; 2008; 46(2):134-8. PubMed ID: 18587707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis.
    Moreira MA; Tilbery CP; Monteiro LP; Teixeira MM; Teixeira AL
    Acta Neurol Scand; 2006 Aug; 114(2):109-13. PubMed ID: 16867033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute immunomodulatory changes during controlled ovarian stimulation: evidence from the first trial investigating the short-term effects of estradiol on biomarkers and B cells involved in autoimmunity.
    Ghirardello A; Gizzo S; Noventa M; Quaranta M; Vitagliano A; Gallo N; Pantano G; Beggio M; Cosma C; Gangemi M; Plebani M; Doria A
    J Assist Reprod Genet; 2015 Dec; 32(12):1765-72. PubMed ID: 26466939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-beta 1a, and high doses of immunoglobulins.
    Sarchielli P; Zaffaroni M; Floridi A; Greco L; Candeliere A; Mattioni A; Tenaglia S; Di Filippo M; Calabresi P
    Mult Scler; 2007 Apr; 13(3):313-31. PubMed ID: 17439900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time.
    Becker-Merok A; Nikolaisen C; Nossent HC
    Lupus; 2006; 15(9):570-6. PubMed ID: 17080911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble and cell surface ICAM-3 in blood and cerebrospinal fluid of patients with multiple sclerosis: influence of methylprednisolone treatment and relevance as markers for disease activity.
    Kraus J; Oschmann P; Engelhardt B; Bauer R; Schiel C; Kern A; Stolz E; Traupe A; Dorndorf W
    Acta Neurol Scand; 2000 Feb; 101(2):135-9. PubMed ID: 10685862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Change of interleukin-4 and interleukin-12 levels after therapy of multiple sclerosis relapse with methylprednisolone].
    Bartosik-Psujek H; Magryś A; Montewka-Kozioł M; Stelmasiak Z
    Neurol Neurochir Pol; 2005; 39(3):207-12. PubMed ID: 15981158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity.
    Ueda-Hayakawa I; Tanimura H; Osawa M; Iwasaka H; Ohe S; Yamazaki F; Mizuno K; Okamoto H
    Rheumatology (Oxford); 2013 Sep; 52(9):1658-66. PubMed ID: 23685362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels.
    Babaloo Z; Aliparasti MR; Babaiea F; Almasi S; Baradaran B; Farhoudi M
    Immunol Lett; 2015 Apr; 164(2):76-80. PubMed ID: 25625963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.
    Then Bergh F; Kümpfel T; Schumann E; Held U; Schwan M; Blazevic M; Wismüller A; Holsboer F; Yassouridis A; Uhr M; Weber F; Daumer M; Trenkwalder C; Auer DP
    BMC Neurol; 2006 May; 6():19. PubMed ID: 16719908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate.
    Azoulay D; Vachapova V; Shihman B; Miler A; Karni A
    J Neuroimmunol; 2005 Oct; 167(1-2):215-8. PubMed ID: 16083971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis.
    Piazza F; DiFrancesco JC; Fusco ML; Corti D; Pirovano L; Frigeni B; Mattavelli L; Andreoni S; Frigo M; Ferrarese C; Tredici G; Cavaletti G
    J Neuroimmunol; 2010 Mar; 220(1-2):104-7. PubMed ID: 20149932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BAFF is elevated in serum of patients with Wegener's granulomatosis.
    Krumbholz M; Specks U; Wick M; Kalled SL; Jenne D; Meinl E
    J Autoimmun; 2005 Dec; 25(4):298-302. PubMed ID: 16242914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal study of chemokine receptor expression on peripheral lymphocytes in multiple sclerosis: CXCR3 upregulation is associated with relapse.
    Mahad DJ; Lawry J; Howell SJ; Woodroofe MN
    Mult Scler; 2003 Mar; 9(2):189-98. PubMed ID: 12708814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
    Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
    Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen.
    Hébert V; Maho-Vaillant M; Golinski ML; Petit M; Riou G; Boyer O; Musette P; Calbo S; Joly P
    Front Immunol; 2021; 12():666022. PubMed ID: 34054835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genes differentially expressed by methylprednisolone in vivo in CD4 T lymphocytes from multiple sclerosis patients: potential biomarkers.
    De Andres C; García MI; Goicoechea H; Martínez-Ginés ML; García-Domínguez JM; Martín ML; Romero-Delgado F; Benguría A; Sanjurjo M; López-Fernández LA
    Pharmacogenomics J; 2018 Jan; 18(1):98-105. PubMed ID: 27670768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.